Business Context and Reporting Period
Company: Eastman Kodak Company
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2001
Business Overview: Kodak is engaged in developing, manufacturing, and marketing traditional and digital imaging products, services, and solutions for consumers, professionals, healthcare providers, and commercial customers. The company operates through three primary reportable segments: Photography, Health Imaging, and Commercial Imaging, plus an "All Other" category.
Key Financial Metrics
| Metric (in millions) | 2001 | 2000 | Change |
|---|---|---|---|
| Net Sales | $13,234 | $13,994 | -5% |
| Gross Profit | $4,564 | $5,619 | -19% |
| Gross Margin | 34.5% | 40.2% | -5.7 pts |
| Earnings from Operations | $345 | $2,214 | -84% |
| Net Earnings | $76 | $1,407 | -95% |
| Diluted EPS | $0.26 | $4.59 | -94% |
| Operating Cash Flow | $2,065 | $982 | +110% |
| Total Debt (Short + Long Term) | $3,200 | $3,374 | -5% |
| Working Capital (excl. borrowings) | $863 | $1,482 | -42% |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 5% to $13.2 billion, driven primarily by an 8% decline in the Photography segment ($9.4 billion) due to lower consumer film volumes, price competition, and digital substitution. Health Imaging (+2%) and Commercial Imaging (+3%) saw modest growth.
- Profitability Collapse: Net earnings plummeted 95% to $76 million. This was largely due to a 5.7 percentage point drop in gross margins and significant one-time charges.
- Restructuring and Impairments: The company recorded $830 million in pre-tax charges ($583 million after-tax) related to restructuring programs, asset impairments, and other items. Specific charges included:
- $698 million for restructuring (severance, asset write-downs, exit costs).
- $77 million for the Wolf Camera bankruptcy.
- $41 million for environmental reserves.
- $20 million for the Kmart bankruptcy.
- Segment Performance:
- Photography: Operating earnings dropped 45% to $787 million. Consumer film sales declined 7%, while digital camera sales volume grew 35% but were offset by price declines.
- Health Imaging: Operating earnings fell 38% to $323 million due to margin compression from price declines and a shift to lower-margin digital equipment.
- Commercial Imaging: Operating earnings decreased 29% to $165 million.
Guidance, Outlook, and Risks
- 2002 Outlook: Management expects 2002 to be a difficult economic year with revenues level with 2001. Earnings improvement is anticipated in the second half of 2002, with a gradual economic upturn expected in 2003.
- Cost Actions: The company plans to complete 2001 restructuring programs to improve cost competitiveness. Capital spending is expected to be reduced to a range of $550 million to $600 million in 2002.
- Liquidity: Kodak expects to generate $6 billion in cash flow over the next six years. It maintains $2.45 billion in revolving credit facilities and $1.1 billion in commercial paper outstanding.
- Key Risks:
- Digital Substitution: Continued shift from analog to digital products threatens traditional film and paper sales.
- Economic Conditions: Global economic weakness and the impact of the September 11, 2001 attacks on consumer spending and travel.
- Environmental Liabilities: Significant accrued liabilities ($162 million) for remediation at current and former sites, with potential for additional costs.
- Joint Venture Contingency: A "Termination Event" occurred in the Express Stop Financing (ESF) joint venture due to a credit downgrade of partner Dana Corporation, potentially requiring additional capital or renegotiation of debt.
Investor Verification Checklist
- Restructuring Execution: Verify the actual cash outflow and savings realization from the $698 million restructuring program announced in 2001.
- Digital Transition: Assess the growth trajectory of digital camera and online services (Ofoto) relative to the decline in traditional film volumes.
- Environmental Accruals: Monitor updates on the $162 million environmental liability, particularly regarding the Kodak Park site and former non-imaging health business sites.
- ESF Joint Venture: Track the resolution of the Termination Event with the Express Stop Financing joint venture and any required capital infusions.
- Margin Recovery: Evaluate whether gross margins can stabilize or improve given the intense price competition in both traditional and digital markets.